Crossmark

Preliminary results suggest the potential of evaluating combined bFGF and TNF-β concentrations for differentiating papillary thyroid cancer from benign nodular goiter

Crossref DOI link: https://doi.org/10.1038/s41598-025-00255-4

Published Online: 2025-05-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ćwiklińska-Dworakowska, Magdalena

Gacuta, Karolina Marta

Kamińska, Joanna

Milewska, Anna Justyna

Matowicka-Karna, Joanna

Koper-Lenkiewicz, Olga Martyna
License Information

Text and Data Mining valid from 2025-05-02

Version of Record valid from 2025-05-02
More Information

Article History

Received: 28 December 2024

Accepted: 28 April 2025

First Online: 2 May 2025

Declarations

:

: The authors declare no competing interests.

: The research followed the guidelines set forth in the Declaration of Helsinki, and the protocol was approved by the Bioethics Human Research Committee at the Medical University of Bialystok (Permission No. APK.002.356.2022). Before participating in the study, all individuals provided informed consent.

Document is current

Any future updates will be listed below